Frontiers in Cardiovascular Medicine

DECEMBER 18, 2023

Methods We carried out a case-control study to identify circulating miRNAs associated with CHCM. We performed a clinical, echocardiographic, and laboratory evaluation and profiled circulating miRNA in the serum samples. Results Differences between groups were observed in clinical variables and in the analysis of miRNAs.

Cardiomyopathy 84

Cardiomyopathy Circulation Biomarkers Laboratory 84

Stroke Journal

JANUARY 30, 2025

Background:The effect of renal dysfunction on early infarct growth rate (IGR) in anterior circulation large vessel occlusion (ACLVO) stroke is not well studied. Renal dysfunction was assessed based on serum creatinine and estimated glomerular filtration rate (eGFR) on presenting laboratories. mL/min/1.73m2, p < 0.05).

Biomarkers 40

Biomarkers Circulation Stroke Strokes 40

DAIC

FEBRUARY 3, 2025

By using molar units, laboratory professionals and clinicians know the Lp(a) measurements reflect the number of particles rather than any difference in the size of the particles. "We Circulation. Roche has an unrivaled ability to provide access to testing at scale and is committed to advancing innovation in preventive cardiology.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146638-A4146638, November 12, 2024. Thus, levels above these thresholds for both apo B and hsCRP are associated with high ASCVD risk.Conclusion(s):The study demonstrates that apo B exhibits high discriminatory and diagnostic accuracy, making it a suitable ASCVD risk biomarker compared to hsCRP.

Biomarkers 40

Biomarkers Cardiovascular Disease Laboratory Plaque 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4148010-A4148010, November 12, 2024. Laboratory values including BNP, CRP, D-dimer, ferritin, fibrinogen, lactate and troponin were analyzed for correlation with echo findings.Results:TAPSE was significantly lower in deceased patients (1.9± 0.4cm vs 1.3±0.6 cm, P< 0.05).

COVID-19 40

COVID-19 Laboratory Biomarkers Echocardiogram 40

Circulation

JANUARY 15, 2024

Circulation, Volume 149, Issue 3 , Page 251-266, January 16, 2024. It outlines the pathophysiology of CAC and reviews laboratory, histopathological, and genetic studies, as well as imaging findings, to characterize different types of calcification and to elucidate their implications.

Coronary Artery Disease 45

Coronary Artery Disease Atherosclerosis Laboratory Plaque 45

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4147019-A4147019, November 12, 2024. Blood samples were collected, and various laboratory parameters were measured at day-1, day-3, and day-7. The fractional excretion of sodium (FeNa) and FeUa were calculated.Results:The mean age of participants was 52.32 ± 14.04

Heart Failure 40

Heart Failure Kidney Disease Laboratory Hospital 40